nodes	percent_of_prediction	percent_of_DWPC	metapath
Ardeparin—SERPIND1—larynx—esophageal cancer	0.526	0.725	CbGeAlD
Ardeparin—SERPIND1—neck—esophageal cancer	0.139	0.192	CbGeAlD
Ardeparin—SERPIND1—lung—esophageal cancer	0.0603	0.0831	CbGeAlD
Ardeparin—Skin necrosis—Cisplatin—esophageal cancer	0.0161	0.0588	CcSEcCtD
Ardeparin—Nodule—Methotrexate—esophageal cancer	0.0105	0.0384	CcSEcCtD
Ardeparin—Diabetic—Methotrexate—esophageal cancer	0.00927	0.0338	CcSEcCtD
Ardeparin—Skin necrosis—Methotrexate—esophageal cancer	0.00885	0.0323	CcSEcCtD
Ardeparin—Hypertriglyceridaemia—Capecitabine—esophageal cancer	0.00724	0.0264	CcSEcCtD
Ardeparin—Haematoma—Capecitabine—esophageal cancer	0.00661	0.0241	CcSEcCtD
Ardeparin—Blood triglycerides increased—Capecitabine—esophageal cancer	0.00634	0.0231	CcSEcCtD
Ardeparin—Thrombosis—Capecitabine—esophageal cancer	0.00587	0.0214	CcSEcCtD
Ardeparin—Pain—Carboplatin—esophageal cancer	0.00586	0.0214	CcSEcCtD
Ardeparin—Hepatocellular injury—Cisplatin—esophageal cancer	0.00564	0.0205	CcSEcCtD
Ardeparin—Hyperkalaemia—Cisplatin—esophageal cancer	0.00554	0.0202	CcSEcCtD
Ardeparin—Osteoporosis—Methotrexate—esophageal cancer	0.00552	0.0201	CcSEcCtD
Ardeparin—Body temperature increased—Carboplatin—esophageal cancer	0.00542	0.0198	CcSEcCtD
Ardeparin—Skin exfoliation—Cisplatin—esophageal cancer	0.00538	0.0196	CcSEcCtD
Ardeparin—Injection site pain—Capecitabine—esophageal cancer	0.00509	0.0186	CcSEcCtD
Ardeparin—Liver disorder—Methotrexate—esophageal cancer	0.00454	0.0165	CcSEcCtD
Ardeparin—Paralysis—Methotrexate—esophageal cancer	0.00445	0.0162	CcSEcCtD
Ardeparin—Inflammation—Capecitabine—esophageal cancer	0.00428	0.0156	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00423	0.0154	CcSEcCtD
Ardeparin—Skin exfoliation—Capecitabine—esophageal cancer	0.00397	0.0145	CcSEcCtD
Ardeparin—Ecchymosis—Capecitabine—esophageal cancer	0.00376	0.0137	CcSEcCtD
Ardeparin—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00369	0.0134	CcSEcCtD
Ardeparin—Diabetes mellitus—Capecitabine—esophageal cancer	0.00347	0.0126	CcSEcCtD
Ardeparin—Vascular purpura—Capecitabine—esophageal cancer	0.00337	0.0123	CcSEcCtD
Ardeparin—Inflammation—Methotrexate—esophageal cancer	0.00319	0.0116	CcSEcCtD
Ardeparin—Atrial fibrillation—Capecitabine—esophageal cancer	0.00318	0.0116	CcSEcCtD
Ardeparin—Vasculitis—Methotrexate—esophageal cancer	0.00317	0.0116	CcSEcCtD
Ardeparin—Dermatitis bullous—Capecitabine—esophageal cancer	0.00316	0.0115	CcSEcCtD
Ardeparin—Purpura—Capecitabine—esophageal cancer	0.00313	0.0114	CcSEcCtD
Ardeparin—Myocardial infarction—Cisplatin—esophageal cancer	0.00309	0.0113	CcSEcCtD
Ardeparin—Cardiac failure—Capecitabine—esophageal cancer	0.00309	0.0113	CcSEcCtD
Ardeparin—Skin exfoliation—Methotrexate—esophageal cancer	0.00295	0.0108	CcSEcCtD
Ardeparin—Ecchymosis—Methotrexate—esophageal cancer	0.0028	0.0102	CcSEcCtD
Ardeparin—Pulmonary oedema—Methotrexate—esophageal cancer	0.00275	0.01	CcSEcCtD
Ardeparin—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00272	0.0099	CcSEcCtD
Ardeparin—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00266	0.0097	CcSEcCtD
Ardeparin—Diabetes mellitus—Methotrexate—esophageal cancer	0.00258	0.00941	CcSEcCtD
Ardeparin—Alopecia—Cisplatin—esophageal cancer	0.0025	0.00912	CcSEcCtD
Ardeparin—Erythema—Cisplatin—esophageal cancer	0.00246	0.00898	CcSEcCtD
Ardeparin—Pneumonia—Capecitabine—esophageal cancer	0.00234	0.00852	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00232	0.00846	CcSEcCtD
Ardeparin—Myocardial infarction—Capecitabine—esophageal cancer	0.00228	0.00831	CcSEcCtD
Ardeparin—Anaemia—Cisplatin—esophageal cancer	0.00228	0.0083	CcSEcCtD
Ardeparin—Malaise—Cisplatin—esophageal cancer	0.00222	0.0081	CcSEcCtD
Ardeparin—Haematuria—Capecitabine—esophageal cancer	0.00222	0.00808	CcSEcCtD
Ardeparin—Haemoglobin—Capecitabine—esophageal cancer	0.0021	0.00764	CcSEcCtD
Ardeparin—Haemorrhage—Capecitabine—esophageal cancer	0.00209	0.00761	CcSEcCtD
Ardeparin—Oedema peripheral—Capecitabine—esophageal cancer	0.00206	0.00749	CcSEcCtD
Ardeparin—Oedema—Cisplatin—esophageal cancer	0.00201	0.00733	CcSEcCtD
Ardeparin—Anaphylactic shock—Cisplatin—esophageal cancer	0.00201	0.00733	CcSEcCtD
Ardeparin—Thrombocytopenia—Cisplatin—esophageal cancer	0.00197	0.00718	CcSEcCtD
Ardeparin—Eosinophilia—Methotrexate—esophageal cancer	0.00192	0.007	CcSEcCtD
Ardeparin—Alopecia—Capecitabine—esophageal cancer	0.00184	0.00672	CcSEcCtD
Ardeparin—Erythema—Capecitabine—esophageal cancer	0.00182	0.00662	CcSEcCtD
Ardeparin—Dyspnoea—Cisplatin—esophageal cancer	0.00179	0.00654	CcSEcCtD
Ardeparin—Pneumonia—Methotrexate—esophageal cancer	0.00174	0.00634	CcSEcCtD
Ardeparin—Pain—Cisplatin—esophageal cancer	0.00172	0.00627	CcSEcCtD
Ardeparin—Anaemia—Capecitabine—esophageal cancer	0.00168	0.00612	CcSEcCtD
Ardeparin—Feeling abnormal—Cisplatin—esophageal cancer	0.00166	0.00604	CcSEcCtD
Ardeparin—Haematuria—Methotrexate—esophageal cancer	0.00165	0.00601	CcSEcCtD
Ardeparin—Malaise—Capecitabine—esophageal cancer	0.00164	0.00597	CcSEcCtD
Ardeparin—Body temperature increased—Cisplatin—esophageal cancer	0.00159	0.0058	CcSEcCtD
Ardeparin—Haemoglobin—Methotrexate—esophageal cancer	0.00156	0.00569	CcSEcCtD
Ardeparin—Haemorrhage—Methotrexate—esophageal cancer	0.00155	0.00566	CcSEcCtD
Ardeparin—Confusional state—Capecitabine—esophageal cancer	0.00149	0.00545	CcSEcCtD
Ardeparin—Oedema—Capecitabine—esophageal cancer	0.00148	0.0054	CcSEcCtD
Ardeparin—Hypersensitivity—Cisplatin—esophageal cancer	0.00148	0.0054	CcSEcCtD
Ardeparin—Shock—Capecitabine—esophageal cancer	0.00146	0.00532	CcSEcCtD
Ardeparin—Thrombocytopenia—Capecitabine—esophageal cancer	0.00145	0.00529	CcSEcCtD
Ardeparin—Diarrhoea—Cisplatin—esophageal cancer	0.00138	0.00502	CcSEcCtD
Ardeparin—Alopecia—Methotrexate—esophageal cancer	0.00137	0.005	CcSEcCtD
Ardeparin—Erythema—Methotrexate—esophageal cancer	0.00135	0.00493	CcSEcCtD
Ardeparin—Dyspnoea—Capecitabine—esophageal cancer	0.00132	0.00482	CcSEcCtD
Ardeparin—Pain—Capecitabine—esophageal cancer	0.00127	0.00462	CcSEcCtD
Ardeparin—Anaemia—Methotrexate—esophageal cancer	0.00125	0.00456	CcSEcCtD
Ardeparin—Feeling abnormal—Capecitabine—esophageal cancer	0.00122	0.00445	CcSEcCtD
Ardeparin—Malaise—Methotrexate—esophageal cancer	0.00122	0.00444	CcSEcCtD
Ardeparin—Nausea—Cisplatin—esophageal cancer	0.00119	0.00435	CcSEcCtD
Ardeparin—Urticaria—Capecitabine—esophageal cancer	0.00118	0.00429	CcSEcCtD
Ardeparin—Body temperature increased—Capecitabine—esophageal cancer	0.00117	0.00427	CcSEcCtD
Ardeparin—Confusional state—Methotrexate—esophageal cancer	0.00111	0.00406	CcSEcCtD
Ardeparin—Anaphylactic shock—Methotrexate—esophageal cancer	0.0011	0.00402	CcSEcCtD
Ardeparin—Hypersensitivity—Capecitabine—esophageal cancer	0.00109	0.00398	CcSEcCtD
Ardeparin—Thrombocytopenia—Methotrexate—esophageal cancer	0.00108	0.00394	CcSEcCtD
Ardeparin—Pruritus—Capecitabine—esophageal cancer	0.00105	0.00382	CcSEcCtD
Ardeparin—Diarrhoea—Capecitabine—esophageal cancer	0.00101	0.0037	CcSEcCtD
Ardeparin—Dyspnoea—Methotrexate—esophageal cancer	0.000984	0.00359	CcSEcCtD
Ardeparin—Pain—Methotrexate—esophageal cancer	0.000944	0.00344	CcSEcCtD
Ardeparin—Headache—Capecitabine—esophageal cancer	0.000929	0.00339	CcSEcCtD
Ardeparin—Feeling abnormal—Methotrexate—esophageal cancer	0.00091	0.00332	CcSEcCtD
Ardeparin—Nausea—Capecitabine—esophageal cancer	0.000881	0.00321	CcSEcCtD
Ardeparin—Urticaria—Methotrexate—esophageal cancer	0.000877	0.0032	CcSEcCtD
Ardeparin—Body temperature increased—Methotrexate—esophageal cancer	0.000873	0.00318	CcSEcCtD
Ardeparin—Hypersensitivity—Methotrexate—esophageal cancer	0.000813	0.00296	CcSEcCtD
Ardeparin—Pruritus—Methotrexate—esophageal cancer	0.000781	0.00285	CcSEcCtD
Ardeparin—Diarrhoea—Methotrexate—esophageal cancer	0.000755	0.00275	CcSEcCtD
Ardeparin—Headache—Methotrexate—esophageal cancer	0.000691	0.00252	CcSEcCtD
Ardeparin—Nausea—Methotrexate—esophageal cancer	0.000656	0.00239	CcSEcCtD
